Sheila Connelly
Synthetic Biologics Inc., USA
Biography
Sheila Connelly is Vice President, Research, at Synthetic Biologics, Inc., a clinical-stage company focused on gut microbiome therapeutics to protect and restore patient health. She has over 20 years of experience in the biotechnology and pharmaceutical industries ranging from start-ups to large pharma. She served as VP Research at GrayBug Vision, Inc., a Johns Hopkins University spinout and cofounded Advanced Vision Therapies, Inc., both ocular therapeutic startups. She served as Senior Director of Translational Research with Intrexon, Corp., and as Group Leader at Genetic Therapy, Inc., a Novartis Company. She published over 40 peer-reviewed scientific articles and has numerous research grant awards and issued patents. She earned her Ph.D. in Molecular Biology from Columbia University and completed postdoctoral training under an awarded NSF fellowship at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland.
Abstract
Abstract : Protection of the gut microbiome from antibiotic-mediated damage